In an advance toward earlier diagnosis of cancer and other disorders, scientists are reporting development of a potentially fast, simple and inexpensive blood test to detect disease “biomarkers.” The study is scheduled for the Dec. 26 issue of ACS’ Journal of the American Chemical Society.
Cagri A. Savran and colleagues explain that serum biomarkers can reveal critical information about the onset and progression of many diseases. Several roadblocks hinder clinical use of existing biomarker tests, which will demand smaller sensors, faster detection times, and less expensive ways of analyzing samples of blood and other body fluids.
The study describes development of an integrated serum biomarker detection system for the folate receptor and testing of blood samples from patients with different types of cancer. Researchers captured the folate receptors — proteins that are biomarkers for the growth of cancer cells — with microscopic magnetic beads and assembled them to form a structure termed a “diffraction grating.” A laser beam focused on the grating yielded a pattern that could potentially be used to determine the biomarker concentration and thus the state of tumor growth.
“The same principles presented here should apply for detection of many other disease markers present in various body fluids,” the researchers stated. “Due to its simplicity and high sensitivity, we expect this method to be extremely useful both in research laboratories and in development of devices for point-of-care diagnostics.”
Source: ACS
Related stories:
A new biomarker for early cancer detection? Research reveals that 'microRNA' may fit the bill
Scientists at Fred Hutchinson Cancer Research Center have discovered that microRNAs – molecular workhorses that regulate gene expression – are released by cancer cells and circulate in the blood, which gives them the potential to become a new class of biomarkers to detect cancer at its earliest stages. Muneesh Tewari, M.D., Ph.D., and colleagues describe their findings in the July 28 issue of the
Proceedings of the National Academy of Sciences.
Closing coal-burning power plant in China and improved cognitive development in children
Closing coal-fired power plants can have a direct, positive impact on children's cognitive development and health according to a study released by the Columbia Center for Children's Environmental Health (CCCEH) at Columbia University's Mailman School of Public Health. The study allowed researchers to track and compare the development of two groups of children born in Tongliang, a city in China's Chongqing Municipality – one in utero while a coal-fired power plant was operating in the city and one in utero after the Chinese government had closed the plant. Among the first group of children, prenatal exposure to coal-burning emissions was associated with significantly lower average developmental scores and reduced motor development at age two. In the second unexposed group, these adverse effects were no longer observed; and the frequency of delayed motor developmental was significantly reduced. The study findings are published in the July 14th
Environmental Health Perspectives.
Cancer-killing viruses influence tumor blood-vessel growth
Viruses genetically designed to kill cancer cells offer a promising strategy for treating incurable brain tumors such as glioblastoma, but the body's natural defenses often eliminate the viruses before they can eliminate the tumor.
Gene therapy increases survival for end-stage head and neck cancer
A gene therapy invented at The University of Texas M. D. Anderson Cancer Center is the first to succeed in a U.S. phase III clinical trial for cancer, as announced today at the American Society of Gene Therapy annual meeting in Boston.
Abnormal 'editing' of gene messages may be a cause of lupus
Researchers at Wake Forest University have uncovered evidence that the abnormal “editing” of gene messages in a type of white blood cell may be behind the development of lupus. Scientists hope the finding will lead to earlier diagnosis, a way to monitor patients’ response to therapy and possibly a new way to treat the disease.
Gene variant increases risk of asthma
A tiny variation in a gene known as CHI3L1 increases susceptibility to asthma, bronchial hyperresponsiveness and decline in lung function, researchers report early online in the
New England Journal of Medicine. (The printed version will appear in the April 17 issue). The gene variant causes increased blood levels of YKL-40, a biomarker for asthma. A slightly different version of the genetic variation lowers YKL-40 levels and protects against asthma.
New lab test predicts risk of kidney injury after surgery
A simple laboratory test may provide a new way for doctors to identify patients at risk of developing potentially severe acute kidney injury (AKI) after surgery—up to three days before the problem would otherwise be detected, reports a pilot study in the May 2008 issue of the
Clinical Journal of the American Society of Nephrology.
Study shows how ultrafine particles in air pollution may cause heart disease
Patients prone to heart disease may one day be told by physicians to avoid not only fatty foods and smoking but air pollution too.